Related Experiment Video
Updated: May 10, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
An older man with gout and vision changes
1Office of Bassam Haddad, MD, Jersey City, NJ, USA.
Abstract:
Digoxin is widely used to manage heart failure and atrial fibrillation, and requires careful patient monitoring to avoid toxicity. Vision disturbances are a specific indicator of toxicity and may be the initial sign. Treatment depends on the patient's clinical presentation.
Insights
Digoxin, used for heart failure and atrial fibrillation, requires monitoring for toxicity. Vision disturbances can be an early warning sign of digoxin toxicity, prompting treatment adjustments.
Area of Science:
- Cardiology
- Pharmacology
- Toxicology
Background:
- Digoxin is a crucial medication for managing heart failure and atrial fibrillation.
- Therapeutic use of digoxin necessitates vigilant patient monitoring to prevent adverse effects.
- Digoxin toxicity poses significant risks, requiring prompt recognition and management.
Observation:
- Vision disturbances are a key indicator of potential digoxin toxicity.
- These visual changes may present as the earliest symptom of toxicity.
- Patient presentation dictates the appropriate treatment strategy for digoxin toxicity.
Findings:
- Specific visual symptoms can signal elevated digoxin levels.
- Early identification of visual disturbances aids in timely intervention.
- Tailoring treatment to the patient's clinical status is essential for managing digoxin toxicity.
Implications:
- Recognizing visual disturbances as an early sign of digoxin toxicity improves patient safety.
- Prompt management based on clinical presentation can mitigate severe toxic effects.
- Enhanced awareness among healthcare providers can optimize digoxin therapy outcomes.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Glaucoma: Overview
Photoreceptors and Visual Pathways
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Angle Closure Glaucoma: Treatment
